Synergy Pharmaceuticals Inc (NASDAQ: SGYP) dropped 4.6% to $4.54, following a law firm PR mentioning investigation in potential breaches of fiduciary duty by board of directors. Share volume was 3.9 million, compared to an all-day average of 6.8 million
